Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

23. Juli 2026 15:13 ET | Quelle: The Rosen Law Firm PA

WGS FINAL DEADLINE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages GeneDx Holdings Corp. Investors to Secure Counsel Before Important August 3 Deadline in Securities Class Action - WGS

NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GeneDx Holdings Corp. (NASDAQ: WGS) between April 16, 2025...
20. Juli 2026 15:27 ET | Quelle: The Rosen Law Firm PA

WGS DEADLINE: ROSEN, A LEADING AND LONGSTANDING FIRM, Encourages GeneDx Holdings Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - WGS

NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GeneDx Holdings Corp. (NASDAQ: WGS) between April 16, 2025...
17. Juli 2026 19:45 ET | Quelle: The Rosen Law Firm PA

WGS DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages GeneDx Holdings Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - WGS

NEW YORK, July 17, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GeneDx Holdings Corp. (NASDAQ: WGS) between April 16, 2025...
16. Juli 2026 11:45 ET | Quelle: Robbins Geller Rudman & Dowd LLP

WGS DEADLINE ALERT: Robbins Geller Rudman & Dowd LLP Announces that GeneDx Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - August 3, 2026 Deadline

The case alleges GeneDx and certain of its top executives made false and/or misleading statements to investors.
14. Juli 2026 16:23 ET | Quelle: The Rosen Law Firm PA

ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages GeneDx Holdings Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - WGS

NEW YORK, July 14, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GeneDx Holdings Corp. (NASDAQ: WGS) between April 16, 2025...
13. Juli 2026 18:55 ET | Quelle: Bragar Eagel & Squire

Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against GeneDx Holdings Corp. and Encourages Investors to Contact the Firm

If you purchased or acquired WGS common stock between April 16, 2025 and May 4, 2026 and would like to discuss your legal rights, contact Bragar Eagel & Squire partners Brandon Walker or Melissa...
12. Juli 2026 17:00 ET | Quelle: Robbins Geller Rudman & Dowd LLP

WGS INVESTOR DEADLINE: RGRD Law Announces that GeneDx Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead GeneDx Class Action Lawsuit

The case alleges GeneDx and certain of its top executives made false and/or misleading statements to investors.
11. Juli 2026 18:25 ET | Quelle: The Rosen Law Firm PA

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages GeneDx Holdings Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - WGS

NEW YORK, July 11, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GeneDx Holdings Corp. (NASDAQ: WGS) between April 16, 2025...
08. Juli 2026 23:02 ET | Quelle: The Rosen Law Firm PA

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages GeneDx Holdings Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - WGS

NEW YORK, July 08, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GeneDx Holdings Corp. (NASDAQ: WGS) between April 16, 2025...
08. Juli 2026 07:15 ET | Quelle: Robbins Geller Rudman & Dowd LLP

WGS INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that GeneDx Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

The case alleges GeneDx and certain of its top executives made false and/or misleading statements to investors.

Nächste Seite